Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Salarius Pharmaceuticals, Inc. Common Stock (SLRX)

Pharmaceutical Preparations

https://www.salariuspharma.com

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The Company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

2450 HOLCOMBE BLVD, SUITE J-608
HOUSTON, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/29/2015

Market Cap

1,116,491

Shares Outstanding

3,940,000

Weighted SO

3,938,433

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

AKTX --.--%

AXLA --.--%

MGTA --.--%

HSTO --.--%

TMBR --.--%

ARTLW --.--%

NTRB --.--%

ALRN --.--%

FWBI --.--%

Beta

0.9250

Last Div

0.0000

Range

1.35-7.6

Chg

-0.1400

Avg Vol

2438451

Mkt Cap

1116491

Exch

NASDAQ

Country

US

Phone

832 834 6992

DCF Diff

1.2697

DCF

1.7185

Div Yield

0.0000

P/S

0.0000

EV Multiple

0.3203

P/FV

0.4727

Div Yield %

0.0000

P/E

-0.1737

PEG

0.0016

Payout

0.0000

Current Ratio

2.9817

Quick Ratio

2.9817

Cash Ratio

2.7772

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

26295.4980

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0138

ROA

-1.8190

ROE

-1.4864

ROCE

-2.8007

NI/EBT

1.0000

EBT/EBIT

0.9717

EBIT/Rev

0.0000

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

0.0000

CF/Debt

0.0000

Equity Multi

1.4961

Rec Turnover

0.0000

Pay Turnover

0.0139

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-12.8018

FCF/Share

-12.8018

Cash/Share

5.4509

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.4727

P/B

0.4727

P/S

0.0000

P/E

-0.1737

P/FCF

-0.1453

P/OCF

-0.1461

P/CF

-0.1461

PEG

0.0016

P/S

0.0000

EV Multiple

0.3203

P/FV

0.4727

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 07, 08:30 Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program

Revenue Product Segmentation